Table 5. Medications used in the management of 22 pediatric patients with Crohn’s disease at the time of diagnosis and during follow-up.
Medications | Treated patients, n (%) |
---|---|
Prednisolone | 16 (72.7) |
Azathioprine | 16 (72.7) |
Mesalazine | 12 (54.5) |
Pentasa | 7 (31.8) |
Asacol | 6 (27.3) |
Folic acid | 9 (40.9) |
Iron supplementation | 7 (31.8) |
Omeprazole | 6 (27.3) |
Calcium supplementation | 6 (27.3) |
Multivitamins | 6 (27.3) |
Biological therapy | 5 (22.7) |
Adalimumab | 4 (18.2) |
Infliximab infusion | 2 (9.1) |